These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 968783)

  • 21. [Prophylaxis and treatment of hyperammoniemia].
    Szám I
    Ther Ggw; 1970 Aug; 109(8):1175 passim. PubMed ID: 5531834
    [No Abstract]   [Full Text] [Related]  

  • 22. [Amino acids prevent hepatic encephalopathy. Ornithine-aspartate in hyperammonemia--results of a study].
    Hartung HD
    Fortschr Med; 1989 Mar; 107(8):56. PubMed ID: 2651255
    [No Abstract]   [Full Text] [Related]  

  • 23. [Influence of ornithine-aspartate on the increased GOT activity in bovine serum].
    Sommer H; Unglaub W
    Berl Munch Tierarztl Wochenschr; 1972 Apr; 85(7):123-5. PubMed ID: 5032067
    [No Abstract]   [Full Text] [Related]  

  • 24. [Betaine aspartate in the therapy of liver diseases].
    Cairella M; Volpari B
    Clin Ter; 1972 Mar; 60(6):513-34. PubMed ID: 5038777
    [No Abstract]   [Full Text] [Related]  

  • 25. [Current views on the therapy of hepatic coma].
    Ziegler K
    Z Gesamte Inn Med; 1970 Apr; 25(8):341-3. PubMed ID: 4331690
    [No Abstract]   [Full Text] [Related]  

  • 26. [Modification of experimentally induced hyperammoniemia by different amino acids].
    Wagner K; Schneider G; Zimmermann HB; Schimmelpfennig W; Theuer D
    Z Gesamte Inn Med; 1970 Jul; 25(13):602-4. PubMed ID: 5523270
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of ornithine-aspartate mixture on 15N-ammonia incorporation into urea in intact mice.
    Balestrieri C; De Cristofaro D; Cittadini D
    Life Sci; 1967 Feb; 6(4):337-40. PubMed ID: 6032209
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of ornithine-aspartate on fecal excretion of mevalonate metabolites and the reticuloendothelial system].
    Nakamura H; Ishikawa M
    Igaku To Seibutsugaku; 1971 Nov; 83(5):213-5. PubMed ID: 5170184
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect of L-ornithin-L-aspartate on toxic kidney disorders similar to nephrosis].
    Raab W
    Dtsch Med J; 1972 Dec; 23(12):705-8. PubMed ID: 4659004
    [No Abstract]   [Full Text] [Related]  

  • 30. [The therapy of states of exhaustion with Ornithin-Aspartat].
    Simon KH
    Med Monatsschr; 1968 Jan; 22(1):30-1. PubMed ID: 5707445
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical experiences with heparmez].
    Baumann M
    Z Allgemeinmed; 1970 Jun; 46(17):895-900. PubMed ID: 5509064
    [No Abstract]   [Full Text] [Related]  

  • 32. Kaliopenic nephrosis: protective action of L-ornithine-L-aspartate.
    Raab WP
    Clin Chim Acta; 1972 Jun; 39(1):239-42. PubMed ID: 5038753
    [No Abstract]   [Full Text] [Related]  

  • 33. The therapy of hyperammonemia due to ornithine transcarbamylase defiency in a male neonate.
    Snyderman SE; Sansaricq C; Phansalkar SV; Schacht RC; Norton PM
    Pediatrics; 1975 Jul; 56(1):65-73. PubMed ID: 1153252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of hepatic porphyria].
    Goia A; Nicoară A
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1976; 28(2):105-8. PubMed ID: 4866
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment with aspartic acid in hepatic coma caused by hyperammonemia].
    Fodor O; Popescu S; Grigoraş D; Barbarino F
    Med Interna (Bucur); 1968 Jul; 20(7):781-5. PubMed ID: 5685308
    [No Abstract]   [Full Text] [Related]  

  • 36. [Therapeutic activity of betaine aspartate].
    Nicrosini F
    Clin Ter; 1972 May; 61(3):227-36. PubMed ID: 5050945
    [No Abstract]   [Full Text] [Related]  

  • 37. [Confirmation of a liver-protecting action of L-ornithine-L-aspartate using the experimental model of hypokalaemic liver damage].
    Raab W
    Wien Klin Wochenschr; 1972 May; 84(21):348-9. PubMed ID: 5031515
    [No Abstract]   [Full Text] [Related]  

  • 38. [Critical study of venous blood ammonia in hepatic coma. Diagnosis, surveillance and treatment].
    Dupuy R; Thiroloix J
    Rev Int Hepatol; 1967; 17(1):43-53. PubMed ID: 6060728
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinico-metabolic observations on the use in therapy of a combination of vitamin B-12, folic acid, nicotinamide and amino acids of the arginine group in patients with chronic liver diseases].
    Piro E; Nicoletti A; Ruffolo S
    Minerva Med; 1967 Apr; 58(34 Suppl):1629-33. PubMed ID: 4226052
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical observations on the therapeutic efficiency of the combination: arginine HCl, citrulline, ornithine HCl, vitamin B-12, folic acid and nicotinamide in liver diseases and in anemic deficiency syndromes].
    Drago U; Finotto E; Ongaro G
    Minerva Med; 1967 Apr; 58(34 Suppl):1592-6. PubMed ID: 4226044
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.